---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-024936"
form_type: "8-K"
ticker: "CORT"
cik: "0001088856"
company_name: "CORCEPT THERAPEUTICS INC"
filed_at: "2024-05-23T23:59:59+00:00"
generated_at: "2026-06-01T09:02:48.600681+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Corcept Therapeutics shareholders approve 2024 Incentive Award Plan adding 8M new shares

## Summary
- 2024 Plan replaces 2012 plan; total shares authorized = 8M new + 4,073,955 carryover + lapsed awards.
- All 9 director nominees elected; vote range 56.9M to 65.6M for (excluding broker non-votes).
- Ernst & Young ratified as auditor for FY2024: 86.6M for, 1.7M against.
- Advisory say-on-pay approved: 64.5M for, 1.0M against; 22.5M broker non-votes.
- 2024 Plan passed with 47.0M for, 18.7M against; 22.5M broker non-votes.

## SEC filing metadata
- accession: 0001628280-24-024936
- form_type: 8-K
- ticker: CORT
- cik: 0001088856
- company_name: CORCEPT THERAPEUTICS INC
- filed_at: 2024-05-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1088856/000162828024024936/0001628280-24-024936-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1088856/000162828024024936/cort-20240517.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-024936
- JSON: https://secwatch.observer/filing/0001628280-24-024936.json
- Plain text: https://secwatch.observer/filing/0001628280-24-024936.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.